Last Updated: May 3, 2026

Suppliers and packagers for JUNIOR STRENGTH ADVIL


✉ Email this page to a colleague

« Back to Dashboard


JUNIOR STRENGTH ADVIL

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Haleon Us Holdings JUNIOR STRENGTH ADVIL ibuprofen TABLET, CHEWABLE;ORAL 020944 NDA Haleon US Holdings LLC 0573-0179-20 1 BOTTLE in 1 CARTON (0573-0179-20) / 24 TABLET, CHEWABLE in 1 BOTTLE 2011-06-01
Haleon Us Holdings JUNIOR STRENGTH ADVIL ibuprofen TABLET, CHEWABLE;ORAL 020944 NDA Proficient Rx LP 71205-425-24 1 BOTTLE in 1 CARTON (71205-425-24) / 24 TABLET, CHEWABLE in 1 BOTTLE 2011-06-01
Haleon Us Holdings JUNIOR STRENGTH ADVIL ibuprofen TABLET;ORAL 020267 NDA Haleon US Holdings LLC 0573-0175-11 1 BOTTLE in 1 CARTON (0573-0175-11) / 24 TABLET, COATED in 1 BOTTLE 2011-06-21
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Last updated: August 13, 2025

ppliers for the Pharmaceutical Drug: Junior Strength Advil

Introduction

Junior Strength Advil, a popular over-the-counter analgesic and antipyretic medication, contains ibuprofen as its active ingredient. It is commonly used by children and adolescents to alleviate pain, reduce fever, and manage inflammation. Given the high demand for this medication, it’s vital for stakeholders to comprehend the landscape of suppliers involved in manufacturing and distributing Junior Strength Advil. This analysis delineates the key suppliers, manufacturing chains, and strategic considerations for businesses operating in or entering this segment.

Market Overview and Manufacturing Landscape

Advil, under the brand name of Pfizer Consumer Healthcare, is one of the leading OTC brands globally. The Junior Strength variant, typically packaged in smaller doses (often 100 mg per chewable tablet), caters specifically to pediatric populations. The manufacturing process involves several stages: active pharmaceutical ingredient (API) production, formulation, packaging, and distribution, often involving multiple suppliers at each step.

Primary Suppliers of Active Pharmaceutical Ingredient (API)

The core component of Junior Strength Advil—ibuprofen—depends on a complex global supply chain. Major API manufacturers include:

  • Mitsui & Co. (Japan): One of the leading producers of ibuprofen APIs with a significant footprint in Asia, Mitsubishi’s subsidiaries supply pharmaceutical firms globally.

  • Huaibei Chemsist Co., Ltd. (China): A prominent Chinese API manufacturer with substantial ibuprofen production capacity, supplying various formulations for global markets.

  • Sandoz (Novartis): Part of Novartis, Sandoz manufactures APIs and generic medications, including ibuprofen, leveraging robust production facilities in Europe and Asia.

  • Unichem Laboratories (India): Known for producing high-quality APIs, Unichem supplies ibuprofen APIs to both domestic and international pharmaceutical companies.

  • BASF SE (Germany): A major chemical producer, BASF manufactures pharmaceutical excipients and APIs, including ibuprofen, for global markets.

Note: Many pharmaceutical marketers source APIs through back-to-back agreements with multiple suppliers, emphasizing quality control and cost efficiencies.

Formulation and Manufacturing of Junior Strength Advil

Once APIs are procured, the formulation process involves blending, compressing, and packaging with excipients to produce chewable tablets suitable for pediatric use. Major contract manufacturing organizations (CMOs) and pharmaceutical companies involved in formulation include:

  • Pfizer Inc.: As the original manufacturer, Pfizer oversees quality standards and global distribution. The company often works with CMOs for manufacturing bulk and finished products.

  • Amneal Pharmaceuticals: Known for producing OTC formulations, including pediatric analgesics, with facilities capable of manufacturing Junior Strength Advil.

  • GSK Consumer Healthcare: Partners with various CMOs to produce pediatric formulations with strict adherence to safety standards.

  • Autranet (India): An active contract manufacturer for pediatric medicines, possibly involved in formulations under private labels for Advil.

Distribution Channels and Key Distributors

Distribution of Junior Strength Advil involves a robust network of wholesalers, pharmacies, supermarkets, and online channels.

  • McKesson Corporation: A primary US-based distributor supplying OTC medications, including pediatric analgesics, to pharmacies and hospitals.

  • Cardinal Health: Distributes a broad array of OTC products with a widespread network in North America and beyond.

  • Alliance Healthcare / Walgreens Boots Alliance: Major distributors managing supply chain logistics for retail outlets.

  • Online Retailers: Amazon, Walmart.com, and local e-commerce platforms increasingly account for a significant share of OTC pediatric medication distribution, especially during the COVID-19 pandemic.

Strategic Considerations for Suppliers and Buyers

Stakeholders must evaluate factors such as API sourcing stability, regulatory compliance (FDA approval, GMP adherence), production capacity, and quality assurance. Importantly, increasing geopolitical tensions and supply disruptions emphasize the need for diversifying supplier bases. Manufacturers might also explore local or regional API production to mitigate risks.

Regulatory and Quality Assurance

Suppliers operating in this space must adhere to stringent regulatory standards:

  • FDA cGMP Compliance: Critical for US market approval and safety assurances.

  • EMA Regulations: For products marketed in Europe, compliance with European Medicines Agency standards is mandatory.

  • WHO Good Manufacturing Practices: Certification can facilitate access to emerging markets and ensure consistent product quality.

Recent Trends Impacting Supplier Dynamics

The COVID-19 pandemic highlighted vulnerabilities in global supply chains, prompting pharma companies to reassess supplier diversity. Additionally, advancements in manufacturing technology, such as continuous manufacturing and quality-by-design, improve scalability and reduce costs. The increasing demand for pediatric OTC medications also boosts the development of regional API manufacturing capabilities.

Conclusion

The supply chain for Junior Strength Advil is multifaceted, involving global API manufacturers, formulation specialists, and extensive distribution networks. Key API suppliers include Mitsui & Co., Huaibei Chemsist, Sandoz, Unichem Laboratories, and BASF. Final product manufacturing often involves strategic partnerships with CMOs such as Pfizer’s manufacturing units, Amneal, or GSK. Distribution channels encompass major pharmaceutical wholesalers, retailers, and e-commerce platforms.


Key Takeaways

  • API sourcing is centralized among Asian manufacturers like Huaibei Chemsist and Mitsui but increasingly diversified to mitigate geopolitical risks.
  • Manufacturing cooperation with CMOs enhances flexibility and scalability for pediatric formulations like Junior Strength Advil.
  • Distribution networks are evolving, with e-commerce playing an expanding role alongside traditional retail channels.
  • Regulatory compliance remains paramount across all suppliers to ensure market access and product safety.
  • Market resilience depends on supplier diversification and technological innovation driven by post-pandemic needs.

FAQs

1. Who are the main API suppliers for ibuprofen used in Junior Strength Advil?
Most API suppliers are based in Asia, including Huaibei Chemsist (China), Mitsui & Co. (Japan), and Indian manufacturers like Unichem Laboratories, complemented by European producers like BASF.

2. Do pharmaceutical companies manufacture Junior Strength Advil in-house or through contract manufacturers?
While Pfizer historically manages the manufacturing process, many companies utilize contract manufacturing organizations (CMOs) for scalability, quality, and cost efficiency.

3. How can supply chain disruptions affect the availability of Junior Strength Advil?
Disruptions in API supply, manufacturing delays, or logistical issues can lead to shortages, impacting production and retail availability, especially during global crises like COVID-19.

4. Are there regional differences in suppliers for Junior Strength Advil?
Yes, regional preferences influence supplier choices—US and European markets often rely on local or regional API producers, while Asian markets may depend more on Asian-based suppliers.

5. What regulations must suppliers adhere to when producing components for Junior Strength Advil?
Suppliers must comply with FDA, EMA, and WHO GMP standards, ensuring quality, safety, and efficacy of APIs and finished products across markets.


Sources:
[1] Pfizer Consumer Healthcare: Advil Product Overview.
[2] Pharmaceutical Business Review, "Global API Market Trends," 2022.
[3] MarketsandMarkets, "OTC Pediatric Medications Market," 2021.
[4] U.S. Food and Drug Administration, "Current Good Manufacturing Practice Regulations," 2022.
[5] BASF Annual Report, "Pharmaceutical Ingredients," 2022.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.